Clinical Trial Update: Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial comparing radiation therapy with or without cetuximab for stage III/IV cancers of the oropharynx, hypopharynx, or larynx. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Laryngeal Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Cetuximab (Erbitux) (Cetuximab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Head and Neck Cancer | Phase 3 | Status: TERMINATED